Your session is about to expire
← Back to Search
Cystic fibrosis patients for Cystic Fibrosis
N/A
Waitlist Available
Led By Amanda Dye, MD
Research Sponsored by CAMC Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study
Eligible Conditions
- Cystic Fibrosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in pulmonary function status
Morphological variable changes
Resting energy expenditure estimation
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cystic fibrosis patientsExperimental Treatment1 Intervention
Patients with cystic fibrosis who are six year or older, who regularly receive care at the West Virginia University-Charleston Cystic Fibrosis Center, and agreed to participate in the study.
Find a Location
Who is running the clinical trial?
CAMC Health SystemLead Sponsor
45 Previous Clinical Trials
7,986 Total Patients Enrolled
Amanda Dye, MDPrincipal Investigator - CAMC and WVU-Charleston
Charleston Area Medical Center-Women's & Children's Hospital
West Virginia University School Of Medicine (Medical School)
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger